Top news of the week: 29.12.2020.
Healthcare
Meet The 50 Doctors, Scientists And Healthcare Entrepreneurs Who Became Pandemic Billionaires In 2020
A surge in healthcare stocks has minted more than four dozen new billionaires from just that sector this year, driven largely by the impact of the Covid-19 pandemic.
Biopharma Money on the Move: December 16-22
A roundup of the latest biopharma companies scooping up cash through IPOs and financing rounds.
Ocugen to co-develop Bharat Biotech's COVID-19 vaccine candidate for US
Ocugen to co-develop Bharat Biotech's COVID-19 vaccine candidate for US - Covaxin showed it was safe and triggered immune responses in an ongoing early-stage trial and is currently part of ...
Bharat Biotech completes recruitment of 13,000 volunteers for Phase III trials of Covaxin
Covaxin has been evaluated in approximately 1,000 subjects in Phase I and Phase II clinical trials, with promising safety and immunogenicity results, Bharat Biotech said in a statement.
Neomorph to Leverage $109 Million Series A Funds Against Undruggable Targets
It is already a very Merry Christmas for brand new San Diego-based biotech Neomorph, Inc., which found $109 million under the tree in a Series A financing to advance its proprietary protein ...
Clinical Catch-Up: December 21-25
Even with the holidays among us, there were a number of clinical trial announcements. Here’s a look.
Analyst: Differences Between Two Possible COVID-19 Therapies Noteworthy Research Report
The factors that set Athersys' stem cell product MultiStem apart from a competitor's therapeutic are provided in a Dawson James Securities report.
Regulatory Leadership in the Time of COVID-19 and Beyond
Earlier this year, DIA held its first Regulatory Affairs Leadership Forum as part of DIA Europe 2020.